» Articles » PMID: 18821687

An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2008 Sep 30
PMID 18821687
Citations 251
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Achieving remission is the aim of treatment in rheumatoid arthritis (RA). This should represent minimal arthritis activity and ensure optimal disease outcome. However, we have previously demonstrated a high prevalence of imaging-detected synovial inflammation in RA patients who were in clinical remission. The purpose of this study was to evaluate the long-term significance of subclinical synovitis and its relationship to structural outcome.

Methods: We studied 102 RA patients receiving conventional treatment who had been judged by their consultant rheumatologist to be in remission, as well as 17 normal control subjects. Subjects underwent clinical, laboratory, functional, and quality of life assessments over 12 months. In addition to standard radiography of the hands and feet, imaging of the hands and wrists was performed with musculoskeletal ultrasonography (US) and conventional 1.5 T magnetic resonance imaging (MRI) at baseline and 12 months, using validated acquisition and scoring techniques.

Results: Despite their being in clinical remission, 19% of the patients displayed deterioration in radiographic joint damage over the study period. Scores on musculoskeletal US synovial hypertrophy, power Doppler (PD), and MRI synovitis assessments in individual joints at baseline were significantly associated with progressive radiographic damage (P=0.032, P<0.001, and P=0.002, respectively). Furthermore, there was a significant association between the musculoskeletal US PD score at baseline and structural progression over 12 months in totally asymptomatic metacarpophalangeal joints (P=0.004) and 12 times higher odds of deterioration in joints with increased PD signal (odds ratio 12.21, P<0.001).

Conclusion: Subclinical joint inflammation detected by imaging techniques explains the structural deterioration in RA patients in clinical remission who are receiving conventional therapy. Our findings reinforce the utility of imaging for the accurate evaluation of disease status and the prediction of structural outcome.

Citing Articles

Effectiveness of baricitinib versus sarilumab on disease activity in patients with RA: a propensity score matching study.

Yukishima T, Nakamura Y, Ohmura S, Kobayakawa T Rheumatol Adv Pract. 2025; 9(1):rkaf006.

PMID: 39959132 PMC: 11829163. DOI: 10.1093/rap/rkaf006.


Magnetic Resonance Imaging (MRI)-Based Semi-Quantitative Methods for Rheumatoid Arthritis: From Scoring to Measurement.

Salaffi F, Carotti M, Di Carlo M, Ceccarelli L, Farah S, Poliseno A J Clin Med. 2024; 13(14).

PMID: 39064179 PMC: 11277801. DOI: 10.3390/jcm13144137.


Ultrasonographic Synovitis Is Associated with the Development of Joint Destruction in Patients with Psoriatic Arthritis.

Yamada Y, Inui K, Mandai K, Mamoto K, Koike T, Tateishi C J Pers Med. 2024; 14(6).

PMID: 38929851 PMC: 11205144. DOI: 10.3390/jpm14060630.


Multimodal PA/US imaging in Rheumatoid Arthritis: Enhanced correlation with clinical scores.

Huang Z, Liu D, Mo S, Hong X, Xie J, Chen Y Photoacoustics. 2024; 38:100615.

PMID: 38817689 PMC: 11137597. DOI: 10.1016/j.pacs.2024.100615.


Musculoskeletal ultrasonography in rheumatic diseases.

Capkin E Turk J Med Sci. 2024; 53(6):1537-1551.

PMID: 38813491 PMC: 10760546. DOI: 10.55730/1300-0144.5723.